ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

Life Sciences [q-bio] Microbiology and Parasitology Bacteriology Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Parasitology Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Human health and pathology Infectious diseases

Fichier principal

S1684118220301092.pdf (850.65 Ko)

Origin : Files produced by the author(s)

Accord Elsevier CCSD : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03027655

Submitted on : Monday, August 22, 2022-12:14:57 PM

Last modification on : Tuesday, August 23, 2022-3:03:38 AM

Long-term archiving on: Wednesday, November 23, 2022-9:15:18 PM

Dates and versions

hal-03027655 , version 1 (22-08-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

HAL Id : hal-03027655 , version 1
DOI : 10.1016/j.jmii.2020.04.015
PII : S1684-1182(20)30109-2
PUBMEDCENTRAL : PMC7201239

Cite

Christian Devaux, Jean-Marc Rolain, Didier Raoult. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology and Infection, 2020, 53 (3), pp.425-435. ⟨10.1016/j.jmii.2020.04.015⟩. ⟨hal-03027655⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

IRD CNRS UNIV-AMU

21 View

4 Download